OakChart

Prestige Consumer Healthcare Inc

PBHHealthcare·Drug Manufacturers - Specialty & Generic·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

44.17-0.80 (-1.78%)
2026-11-11 23:23 CET
Market cap
2,131.45 USD m
Revenue, TTM
1,167.08 USD m
Net income, TTM
155.10 USD m
Free cash flow, TTM
214.22 USD m
EPS diluted, TTM
3.25
P/E
13.61
Compare

Price

PBH against its 20, 50 and 200-day averages
2050200miss
45.0050.0055.0060.001.2M2.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PBHclose 44.1720-day 47.8650-day 47.68200-day 53.3244.1752w low

37.9% under the 52-week high of 71.07 on 24 Feb 2026. 52-week low 41.77 on 6 Nov 2026. Last 15 sessions, 27.8% high to low

Volume 0.67× normal · the line is the 50-bar volume average

Profile

PBH
52-week range, 8% of the way up
41.7771.07

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.

IndexRUT
Employees890
IPOFeb 10, 2005
Beta0.31
ATR, 14d2.07
Rel volume0.67
Short float9.09%
Insider own1.47%
Inst own113.81%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.09B
Enterprise Value4.17B
Income155.10M
Sales1.17B
Book/sh41.03
Cash/sh0.98
Dividend Est.-
Dividend TTM-
Dividend Ex-DateDec 27, 2013
Dividend Gr. 3/5Y- -
Payout0.00%
Employees890
IPOFeb 10, 2005

Ratios

P/E13.61
Forward P/E8.69
PEG1.27
P/S1.79
P/B1.08
P/C45.00
P/FCF9.77
EV/EBITDA12.73
EV/Sales3.58
Quick Ratio1.86
Current Ratio2.92
Debt/Eq1.09
LT Debt/Eq1.09
Option/ShortYes / Yes

Earnings

EPS (ttm)3.25
EPS next Y5.08
EPS next Q1.08
EPS this Y2.97%
EPS next Y12.73%
EPS next 5Y6.86%
EPS past 3/5Y- 3.72%
Sales past 3/5Y-1.17% 2.91%
EPS Y/Y TTM-19.73%
Sales Y/Y TTM5.10%
EPS Q/Q-37.97%
Sales Q/Q22.69%
EarningsNov 05 BMO
EPS/Sales Surpr.5.32% 2.18%

Ownership

Insider Own1.47%
Insider Trans-0.09%
Inst Own113.81%
Inst Trans4.06%
ROA3.80%
ROE8.23%
ROIC3.82%
Gross Margin50.33%
Oper. Margin24.95%
Profit Margin13.29%
SMA20-7.71%
SMA50-7.37%
SMA200-17.17%
Trades-

Technical

Shs Outstand47.40M
Shs Float46.70M
Short Float9.09%
Short Ratio7.35
Short Interest4.24M
52W High71.07 -37.85%
52W Low41.77 5.75%
Volatility6.79% 3.82%
ATR (14)2.07
RSI (14)41.15
Beta0.31
Rel Volume0.67
Avg Volume576.96K
Volume386,267

Performance

Perf Week-17.10%
Perf Month-8.93%
Perf Quarter-13.93%
Perf Half Y-14.75%
Perf YTD-28.40%
Perf Year-27.09%
Perf 3Y-23.44%
Perf 5Y-30.22%
Perf 10Y-11.13%
Recom1.71
Target Price65.25
Prev Close44.97
Price44.17
Change %-1.78%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 14, 2026DowngradeOOppenheimerOutperform → Perform
Sep 24, 2025UpgradeSSidotiNeutral → Buy$80+81.1%
Dec 09, 2024DowngradeSSidotiBuy → Neutral$90+103.8%
Jun 21, 2024UpgradeDDA DavidsonNeutral → Buy$65 → $93+110.6%
Nov 17, 2022InitiatedCCanaccord GenuityBuy$71+60.7%
May 10, 2022UpgradeJJefferiesHold → Buy$65 → $70+58.5%
May 09, 2022UpgradeOOppenheimerPerform → Outperform$63+42.6%
Aug 07, 2020DowngradeDDA DavidsonBuy → Neutral
Jun 29, 2020UpgradeSSidotiNeutral → Buy
Apr 14, 2020DowngradeJJefferiesBuy → Hold

Peers

Mkt cap
TickerCompanyMkt cap
PRGOPerrigo Company plc2.30B
HLNHaleon plc ADR40.00B
KVUEKenvue Inc37.09B
CHDChurch & Dwight Co Inc26.44B
BLCOBausch + Lomb Corp7.62B
EPCEdgewell Personal Care Co1.34B
HELEHelen of Troy Ltd888.49M
CLXClorox Co12.95B
SPBSpectrum Brands Holdings Inc2.03B
PGProcter & Gamble Co388.62B

Insider trading

latest 14 of 16
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Zerillo JeffreySenior VP OperationsMay 11 '26Sale52.2835118,35041,810May 12 04:01 PM
Zerillo JeffreySenior VP OperationsMay 07 '26Sale54.3630516,58042,161May 11 04:03 PM
Zerillo JeffreyOfficerMay 11 '26Proposed Sale52.2835118,350May 11 09:38 AM
Zerillo JeffreySenior VP OperationsMay 05 '26Sale54.991,20766,37342,820May 07 04:02 PM
Zerillo JeffreyOfficerMay 07 '26Proposed Sale54.3630516,580May 07 02:32 PM
Zerillo JeffreySenior VP OperationsMay 05 '26Sale55.3234619,14144,334May 06 05:16 PM
Zerillo JeffreyOfficerMay 06 '26Proposed Sale54.991,20766,374May 06 12:27 PM
Zerillo JeffreyOfficerMay 05 '26Proposed Sale55.3234619,141May 05 01:03 PM
Zerillo JeffreySenior VP OperationsFeb 11 '26Sale65.931,00065,93041,048Feb 13 04:37 PM
Zerillo JeffreyOfficerFeb 11 '26Proposed Sale65.931,00065,930Feb 11 10:28 AM
Zerillo JeffreySenior VP OperationsNov 28 '25Sale60.0071943,14042,329Dec 02 04:43 PM
Zerillo JeffreySenior VP OperationsDec 01 '25Sale60.0028116,86042,048Dec 02 04:43 PM
Zerillo JeffreyOfficerDec 01 '25Proposed Sale60.0028116,860Dec 01 11:24 AM
Zerillo JeffreyOfficerNov 28 '25Proposed Sale60.0071943,140Nov 28 01:04 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B

News

latest 14 of 200
  • Prestige Consumer Healthcare Beats On Acquisitions, But A Clear Eyes Relapse Forces Another Guidance Cut (Earnings Whispers) -16.82%
  • Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot (Associated Press)
  • Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results (GlobeNewswire)
  • Prestige Consumer Healthcare's Breathe Right Deal Faces Its First Full-Quarter Test As Shares Slide (Earnings Whispers)
  • Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results (GlobeNewswire)
  • More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve Survey Finds (PR Newswire)
  • Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference (GlobeNewswire)
  • Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek Football Stress Test (PR Newswire)
  • Skyrocketing Beef Prices Finally Have Americans Reaching Their Spending Limit (Bloomberg)
  • Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference (GlobeNewswire)
  • Prestige Consumer Healthcare Inc (PBH) (Q1 2027) Earnings Call Highlights: Record Cash Flow and ... (GuruFocus.com)
  • Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot (Associated Press)
  • Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results (GlobeNewswire)
  • Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-051.1301.0730.530336.31329.147
2026Q12026-08-060.9800.8940.613265.71253.027
2025Q42026-05-131.2301.3901.131281.62293.647
2025Q32026-02-051.1401.1450.971283.44282.217
2025Q22025-11-061.0700.9700.857274.11257.017
2025Q12025-08-070.9501.0000.953249.53260.776
2024Q42025-05-081.3201.2981.001296.52289.557
2024Q32025-02-061.2201.1751.221290.32287.767
2024Q22024-11-071.0901.0851.088283.79282.097
2024Q12024-08-080.9000.8590.976267.14260.426
2023Q42024-05-141.0201.1390.983276.99287.426
2023Q32024-02-081.0601.0411.058282.74280.256
2023Q22023-11-021.0701.0671.069286.32285.226
2023Q12023-08-031.0601.0091.061279.31278.796
2022Q42023-05-041.0701.040-4.831285.87278.926
2022Q32023-02-021.0401.0121.035275.52273.846

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY2.9602.8772.782963.01951.46
2020FY3.2403.2313.254943.37936.15
2021FY4.0604.0324.0401,0871,078
2022FY4.2104.181-1.6501,1281,121
2023FY4.2104.3294.1721,1251,136
2024FY4.5204.5014.2851,1381,131
2025FY4.3804.5403.9101,0891,101
2026FY-4.510--1,284
2027FY-5.084--1,370
2028FY-5.345--1,398
2029FY-5.790--1,416
2030FY-6.030--1,436

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-06706331.36327.53351.1
2026Q3S2026-11-05705334.11327.53351.1
2026Q3S2026-10-28701351.75347.5359.26
2026Q3S2026-10-24700353.1347.5368.7
2026Q3S2026-10-20710353.1347.5368.7
2026Q3S2026-10-18730353.1347.5368.7
2026Q3S2026-10-11740353.1347.5368.7
2026Q3S2026-08-14750353.1347.5368.7
2026Q3S2026-08-13750353.47347.73368.7
2026Q3S2026-08-12750353.47347.73368.72
2026Q3S2026-08-10750353.47347.73368.7
2026Q3S2026-08-06740344.65289.4368.7
2026Q3S2026-08-04720335.17287.7368.72
2026Q3S2026-08-01710324.47287.7358.5

Estimate history

EPS, annual6.344-0.6882.7823.2544.04-1.654.1724.2853.9063.2464
Period201720182019202020212022202320242025TTM
EPS, quarterly1.0881.2211.0010.9530.8570.9711.1310.6130.532
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual1041.179975.777963.01943.3651086.8121127.7251125.3571137.7621088.7051167.08
Period201720182019202020212022202320242025TTM
Sales, quarterly283.785290.317296.518249.53274.114283.444281.617265.71336.307
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual53.04351.79950.08649.91150.27949.69249.82149.50947.31947.397
Period201720182019202020212022202320242025MRQ
Shares, quarterly49.4449.57649.50949.21148.08447.31947.31947.37247.397
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,167.081,088.701,137.761,125.361,127.721,086.81943.37963.01975.78
Cost of Goods Sold Incl. D&A579.67514.07524.59523.46527.51491.03419.83426.35447.05
Gross Profit587.40574.64613.17601.90600.22595.78523.53536.66528.73
Selling, General and Administrative Excl. Other296.19265.23263.93259.47252.41265.86226.13236.31228.55
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income291.21309.41349.24342.43347.80329.92297.40300.36300.18
Interest Expense66.0742.3447.6367.1669.1661.8677.5796.57105.30
Unusual Expense1.360.0012.470.00370.222.1214.6711.36233.96
Net Income Before Taxes212.58257.50284.19276.02-93.92262.46204.11191.15-38.05
Income Taxes57.4867.1969.5866.69-11.6157.0839.4348.87-2.25
Consolidated Net Income155.10190.30214.60209.34-82.31205.38164.68142.28-35.80
Net Income From Continuing Operations155.10190.30214.60209.34-82.31205.38164.68142.28-35.80
Net Income155.10190.30214.60209.34-82.31205.38164.68142.28-35.80
EPS (Recurring)3.283.914.464.173.544.073.462.942.46
EPS (Basic, Before Extraordinaries)3.263.934.324.21-1.654.093.282.81-0.69
EPS (Diluted)3.253.914.294.17-1.654.043.252.78-0.69
EBITDA327.88340.68379.41373.10386.74368.72334.65338.14331.96
Non-Operating Income (Expense)-11.21-9.57-4.950.76-2.34-3.48-1.05-1.281.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.399.629.8912.8211.278.417.326.446.00
Price To Earnings Ratio13.8513.8520.14--13.1013.5613.1824.47
Price To Sales Ratio1.872.653.783.242.772.482.361.951.60
Gross Margin50.3352.7853.8953.4853.2254.8255.5055.7354.19
Operating Margin24.9528.4230.7030.4330.8430.3631.5331.1930.76
Net Margin13.2917.4818.8618.60-7.3018.9017.4614.77-3.67
Shares Outstanding47.4047.3249.5149.8249.6950.2849.9150.0951.80
Market Capitalization2,131.452,131.454,258.763,602.553,111.942,657.552,198.041,843.761,549.28

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue336.31265.71281.62283.44274.11249.53296.52290.32
Cost of Goods Sold Incl. D&A172.48135.22140.76131.22127.71114.38131.57134.23
Gross Profit163.83130.49140.86152.22146.41135.15164.95156.09
Selling, General and Administrative Excl. Other83.1277.9765.3769.7366.7463.3964.0564.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income80.7152.5275.4982.4979.6771.76100.8991.96
Interest Expense30.0313.9511.4310.6710.0410.2010.7611.46
Unusual Expense1.360.000.000.000.000.0012.470.00
Net Income Before Taxes47.4538.5464.7761.8169.1361.7873.9680.15
Income Taxes22.169.3610.8415.1226.9214.3123.8319.12
Consolidated Net Income25.3029.1853.9346.7042.2147.4750.1361.03
Net Income From Continuing Operations25.3029.1853.9346.7042.2147.4750.1361.03
Net Income25.3029.1853.9346.7042.2147.4750.1361.03
EPS (Recurring)0.550.611.130.970.860.951.181.22
EPS (Basic, Before Extraordinaries)0.530.611.140.980.860.961.011.23
EPS (Diluted)0.530.611.130.970.860.951.001.22
EBITDA92.6861.2783.8490.0887.3379.42108.1598.83
Non-Operating Income (Expense)-1.88-0.030.71-10.01-0.500.22-3.71-0.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.033.492.382.491.543.222.552.51
Price To Earnings Ratio13.8512.0915.6715.3014.6418.6320.1419.02
Price To Sales Ratio1.872.042.602.692.773.553.783.49
Gross Margin48.7149.1150.0253.7053.4154.1655.6353.77
Operating Margin24.0019.7726.8129.1029.0628.7634.0331.68
Net Margin7.5210.9819.1516.4715.4019.0216.9121.02
Shares Outstanding47.4047.3747.3247.3248.0849.2149.5149.58
Market Capitalization2,131.452,239.282,804.582,966.303,070.973,945.764,258.763,858.08

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments63.8797.8846.4758.4927.1832.3094.7627.5332.55
Short Term Receivables191.92194.29176.78167.02139.33114.67150.52148.79140.88
Inventories159.13147.71138.72162.12120.34114.96116.03119.88118.55
Other Current Assets16.568.4413.084.126.417.904.354.7411.50
Total Current Assets431.48448.33375.04391.74293.27269.83365.65300.94303.48
Net Property, Plant & Equipment171.25127.8489.3389.5398.53102.7790.7251.1852.55
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets2,880.712,822.782,848.322,869.453,275.613,053.813,054.573,085.793,401.01
Deferred Tax Assets61.9654.0738.4940.9639.8639.78---
Other Assets2.172.475.723.003.272.862.963.133.57
Total Assets3,547.573,455.493,356.903,394.693,710.543,469.053,513.913,441.043,760.61
Short Term Debt Incl. Current Port. of LT Debt12.558.546.159.769.118.456.830.000.00
Accounts Payable22.7918.9338.9862.7455.7645.9862.3856.5661.39
Income Tax Payable0.730.832.5710.642.671.653.210.091.90
Other Current Liabilities84.8578.3369.3577.5775.8866.0677.4670.3359.91
Total Current Liabilities120.92106.62117.05160.72143.42122.14149.88126.98123.20
Long Term Debt1,032.881,035.711,133.501,357.331,497.251,506.171,759.801,798.601,992.95
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities500.67472.86442.08421.39484.78473.83407.81399.57442.52
Other Liabilities5.585.399.198.167.488.6125.4420.0523.33
Total Liabilities1,660.051,620.591,701.821,947.602,132.932,110.752,342.932,345.202,582.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,887.521,834.901,655.081,447.081,577.611,358.301,170.971,095.831,178.61
Total Shareholders Equity1,887.521,834.901,655.081,447.081,577.611,358.301,170.971,095.831,178.61
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,887.521,834.901,655.081,447.081,577.611,358.301,170.971,095.831,178.61
Total Liabilities & Stockholders Equity3,547.573,455.493,356.903,394.693,710.543,469.053,513.913,441.043,760.61
Book Value Per Share39.8937.0633.2229.1231.3827.2123.3821.1622.22
Tangible Book Value Per Share-20.99-19.95-23.95-28.62-33.77-33.97-37.61-38.42-41.90
Full-Time Employees890600570560535505520520530
Price to Book Ratio1.102.382.252.151.691.621.571.301.47
Return on Assets5.436.306.20-2.325.724.724.09-0.998.85
Return on Equity10.2212.3013.50-5.4413.9913.0212.55-3.1533.94
Return on Invested Capital6.527.487.51-2.936.685.754.85-1.2410.71
Quick Ratio2.252.822.021.431.211.271.671.431.50
Current Ratio3.574.203.202.442.042.212.442.372.46

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income155.10190.30214.60209.34-82.31205.38164.68142.28-35.80
Depreciation36.6631.2730.1730.6838.9438.8037.2537.7831.78
Other Funds (Non Cash)51.0630.9834.2725.67387.7116.7120.6514.41242.18
Funds from Operations257.76275.25293.46288.76283.57270.87241.21208.32197.60
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-27.98-17.62-41.94-39.83-53.85-10.95-5.608.80-8.32
Cash from Operating Activities229.78257.63251.51248.93229.72259.92235.61217.12189.28
Capital Expenditures-15.56-11.18-8.22-9.55-7.78-9.64-22.24-17.32-10.48
Net Assets From Acquisitions-1,317.29-123.74-8.250.000.00-247.050.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.0065.91
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-1.76-1.93-0.98-10.56-3.800.000.000.000.00
Other Sources0.000.000.000.000.000.180.000.750.00
Cash from Investing Activities-1,334.62-136.84-17.45-20.11-11.58-256.51-22.24-16.5755.43
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-46.04-152.00-36.71-6.91-42.637.04-9.02-55.40-47.05
Repurchase of Common Pref Stock-46.51-156.28-51.51-25.00-50.000.00-11.87-56.72-49.98
Sale of Common Pref Stock0.474.2914.8018.097.377.042.851.322.93
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net1,085.040.50-139.54-228.60-137.75-11.69-269.16-75.06-200.00
Change in Long Term Debt1,081.170.00-135.00-225.00-137.75-11.69-267.72-74.58-200.00
Issuance of Long Term Debt1,151.1740.000.000.0020.00675.89597.28493.4245.00
Reduction of Long Term Debt-70.00-40.00-135.00-225.00-157.75-687.58-865.00-568.00-245.00
Net Financing Active Other Cash Flow-4.52-4.57-5.83-5.51-5.47-2.92-1.24-0.97-2.28
Other Financing Activities Uses-4.52-4.57-5.83-5.51-5.47-2.92-1.24-0.97-2.28
Cash from Financing Activities1,031.92-156.06-182.07-241.01-185.85-7.57-279.42-131.43-249.33
Exchange Rate Effect0.321.26-0.570.18-0.98-0.963.60-1.89-0.41
Net Change in Cash-72.59-34.0251.41-12.0231.30-5.12-62.4667.23-5.02
Free Cash Flow214.22246.45243.29239.38221.93250.28213.36202.56178.80
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow10.1911.7217.7015.2114.0810.7510.459.268.71
Deferred Taxes & Investment Tax Credit-22.7014.4123.07-60.779.9818.6313.85-40.55

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments46.5289.1363.8762.37119.11139.50
Short Term Receivables244.12187.35191.92190.46199.00168.41
Inventories179.20190.22159.13163.59159.00153.13
Other Current Assets22.2930.1216.5617.0020.3119.48
Total Current Assets492.13496.81431.48433.43497.41480.52
Net Property, Plant & Equipment161.62164.17171.25174.74121.94124.94
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets4,062.323,894.152,880.712,882.782,819.482,823.14
Deferred Tax Assets--61.96---
Other Assets5.5813.432.173.793.443.02
Total Assets4,721.664,568.573,547.573,494.743,442.283,431.62
Short Term Debt Incl. Current Port. of LT Debt13.8323.8012.558.638.628.60
Accounts Payable44.0236.8522.7942.9541.9222.21
Income Tax Payable0.887.570.730.470.475.45
Other Current Liabilities109.7785.5984.8587.5183.5973.41
Total Current Liabilities168.50153.81120.92139.56134.60109.67
Long Term Debt2,113.412,043.641,032.881,070.661,032.401,034.12
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities489.53448.82500.67449.33444.92426.95
Other Liabilities5.555.595.585.755.385.41
Total Liabilities2,777.002,651.861,660.051,665.291,617.311,576.14
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,944.661,916.721,887.521,829.451,824.971,855.48
Total Shareholders Equity1,944.661,916.721,887.521,829.451,824.971,855.48
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,944.661,916.721,887.521,829.451,824.971,855.48
Total Liabilities & Stockholders Equity4,721.664,568.573,547.573,494.743,442.283,431.62
Book Value Per Share41.0340.4639.8938.6637.9537.70
Tangible Book Value Per Share-44.68-41.74-20.99-22.26-20.68-19.66
Full-Time Employees--890---
Price to Book Ratio1.101.191.531.631.662.15
Return on Assets3.804.305.435.475.946.32
Return on Equity8.239.1210.2210.3111.2912.05
Return on Invested Capital0.620.741.851.611.481.64
Quick Ratio1.861.992.251.932.512.99
Current Ratio2.923.233.573.113.704.38

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income25.3029.1853.9346.7042.2147.47
Depreciation11.968.758.357.597.667.67
Other Funds (Non Cash)20.859.585.1615.474.286.07
Funds from Operations73.3747.7063.3373.3571.5367.03
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-35.5123.09-20.494.93-14.0511.98
Cash from Operating Activities37.8770.7942.8478.2957.4979.01
Capital Expenditures-3.62-3.70-5.21-3.03-2.10-0.84
Net Assets From Acquisitions-148.56-1,045.001.80-125.530.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses13.28-15.030.000.00-0.83-1.10
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-138.90-1,063.74-3.41-128.56-2.93-1.94
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.090.00-0.31-45.82-74.25-31.62
Repurchase of Common Pref Stock0.000.00-0.69-45.82-75.00-34.77
Sale of Common Pref Stock0.090.000.380.000.753.15
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net58.231,022.60-37.7339.38-0.54-0.61
Change in Long Term Debt58.651,022.52-40.0040.000.000.00
Issuance of Long Term Debt88.651,022.520.0040.000.000.00
Reduction of Long Term Debt-30.000.00-40.000.000.000.00
Net Financing Active Other Cash Flow-0.02-4.15-0.06-0.29-0.16-4.05
Other Financing Activities Uses-0.02-4.15-0.06-0.29-0.16-4.05
Cash from Financing Activities58.301,018.45-38.10-6.73-74.95-36.28
Exchange Rate Effect0.13-0.250.170.27-0.000.82
Net Change in Cash-42.6125.261.50-56.73-20.4041.62
Free Cash Flow34.2467.0837.6375.2655.3878.17
Price to Free Cash Flow10.199.5611.4711.1012.0314.86

Revenue breakdown

Analgesics2024: 117.70M 2025: 113.94M
Cough and Cold2024: 106.21M 2025: 101.91M
Dermatologicals2024: 128.95M 2025: 125.93M
Eye and Ear Care2024: 183.32M 2025: 142.94M
Gastrointestinal2024: 255.94M 2025: 259.79M
Oral Care2024: 95.03M 2025: 101.05M
Other OTC2024: 13.78M 2025: 15.39M
Women's Health2024: 236.83M 2025: 227.77M
Non-US2024: 240.22M 2025: 238.29M
United States2024: 897.54M 2025: 850.41M
International OTC Healthcare2024: 177.75M 2025: 175.13M
North American OTC Healthcare2024: 960.01M 2025: 913.58M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-309.09%4.2M46.7M560.81K
2026-10-158.49%4.0M46.7M552.64K
2026-09-309.95%4.6M46.7M539.88K
2026-09-1510.27%4.8M46.7M570.52K
2026-08-319.82%4.6M46.7M592.11K
2026-08-149.15%4.3M46.7M665.52K
2026-07-318.18%3.8M46.7M693.34K
2026-07-156.61%3.1M46.7M690.73K
2026-06-306.88%3.2M46.7M717.92K
2026-06-156.28%2.9M46.7M656.58K
2026-05-295.31%2.5M46.7M617.12K
2026-05-155.75%2.7M46.7M578.82K
2026-04-306.27%2.9M46.6M487.88K
2026-04-154.93%2.3M46.6M482.64K
2026-03-315.78%2.7M46.6M425.11K
2026-03-135.36%2.5M46.6M405.51K
2026-02-275.10%2.4M46.6M414.78K
2026-02-134.32%2.0M46.6M410.81K
2026-01-304.69%2.2M46.6M418.15K
2026-01-154.38%2.1M47.4M410.93K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call25.0016.7021.500.004.2450.000.000.933-0.1470.009
call30.0011.8016.500.003.2350.000.000.910-0.1370.011
call35.007.0011.400.002.3090.000.000.874-0.1210.014
call40.002.006.500.001.5480.000.000.794-0.0980.020
call45.000.004.902.561.9122.000.000.532-0.2800.027
call50.000.004.902.282.5614.000.000.457-0.3970.027
call55.000.004.900.000.9720.000.000.086-0.0600.011
call60.000.004.900.121.24915.000.000.071-0.0660.009
call65.000.004.900.051.49120.000.000.061-0.0710.008
call70.000.004.900.001.7060.000.000.055-0.0740.008
put25.000.004.900.002.8760.000.00-0.067-0.1450.009
put30.000.004.900.002.1220.000.00-0.090-0.1330.011
put35.000.004.900.001.4620.000.00-0.126-0.1170.014
put40.000.004.900.660.8445.000.00-0.206-0.0940.020
put45.000.054.901.711.6353.000.00-0.468-0.2750.027
put50.003.508.201.061.6441.000.00-0.543-0.3910.027
put55.008.5013.2011.202.1150.000.00-0.914-0.0540.011
put60.0013.5018.200.002.5040.000.00-0.929-0.0590.009
put65.0018.5023.200.002.8360.000.00-0.939-0.0630.008
put70.0023.5028.200.003.1290.000.00-0.945-0.0670.008

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-08-148-KCurrent report2026-08-10SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-07-158-KCurrent report2026-07-15SEC
2026-07-098-K/A2026-06-12SEC
2026-07-07SCHEDULE 13G/ASEC
2026-07-068-KCurrent report2026-06-30SEC
2026-06-308-K/A2026-06-12SEC
2026-06-29ARSAnnual report to security holders. 2026-03-31SEC
2026-06-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-29SEC
2026-06-168-KCurrent report2026-06-12SEC
2026-05-1410-KAnnual report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-144/A2026-05-02SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-11144Filing for proposed sale of securities under Rule 144.SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-07144Filing for proposed sale of securities under Rule 144.SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500120.44K4
2026-040000
2026-030000
2026-020065.93K1
2026-010000
2025-120016.86K1
2025-1100221.19K2

Institutional holders

Manager% owned
BlackRock, Inc.16.53%
ARIEL INVESTMENTS, LLC10.28%
VANGUARD PORTFOLIO MANAGEMENT LLC5.96%
DIMENSIONAL FUND ADVISORS LP5.59%
FULLER & THALER ASSET MANAGEMENT, INC.4.92%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
STATE STREET CORP4.47%
BRANDES INVESTMENT PARTNERS, LP4.33%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC3.95%
GEODE CAPITAL MANAGEMENT, LLC2.72%

Funds

Fund% owned
Fidelity Advisor Floating Rate High Income Fund25.44%
T. Rowe Price Institutional Floating Rate Fund15.12%
T. Rowe Price Floating Rate Fund12.71%
Strategic Income Opportunities Fund9.83%
VANGUARD HIGH-YIELD CORPORATE FUND7.94%
Invesco Senior Floating Rate Fund7.36%
iShares Core S&P Small-Cap ETF6.03%
Income Fund4.38%
Nuveen High Yield Income Fund4.26%
Undiscovered Managers Behavioral Value Fund3.93%

OakChart. PBH. Cached 15 minutes.